Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT01757067
Eligibility Criteria:
Inclusion Criteria:
* Patients with reduced ejection fraction (EF ≤45%) demonstrated by transthoracic echocardiogram and deemed to be non-ischemic by nuclear stress test or cardiac catheterization.
* Patients with \>20% PVCs on 24 hour holter-recording
* Patient is 18 years of age or older
* Optimized medical therapy on stable therapy for minimum 3 months with no changes in beta-blocker, ACE-I/ARB, digoxin doses (varying diuretic doses permitted).
Exclusion Criteria:
* Patients who are under the age of 18 years of age
* Patients with \>2 dominant PVC morphologies
* Patients with cardiac surgery in previous 3 months or scheduled for following 6 months
* Patients who were implanted with a biventricular device during the last three months or single/dual chamber device (with ventricular pacing \>10%) during the last three months
* Significant symptoms associated with PVCs that would make favor immediate ablation
* Intracardiac mural thrombus or myxoma
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01757067
Study Brief:
Protocol Section:
NCT01757067